These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 28257894)

  • 41. Role of D1/D2 dopamine and N-methyl-D-aspartate (NMDA) receptors in morphine tolerance and dependence in mice.
    Verma A; Kulkarni SK
    Eur Neuropsychopharmacol; 1995 Jun; 5(2):81-7. PubMed ID: 7549459
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Dopamine receptor knockout mice].
    Aiba A
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1999 Dec; 19(5):251-5. PubMed ID: 10803208
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Phospholipase Cbeta1 modulates pain sensitivity, opioid antinociception and opioid tolerance formation.
    Liu NJ; vonGizycki H; Gintzler AR
    Brain Res; 2006 Jan; 1069(1):47-53. PubMed ID: 16405873
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dopamine D1 and D3 Receptors Modulate Heroin-Induced Cognitive Impairment through Opponent Actions in Mice.
    Zhu Y; Wang Y; Lai J; Wei S; Zhang H; Yan P; Li Y; Qiao X; Yin F
    Int J Neuropsychopharmacol; 2017 Mar; 20(3):257-268. PubMed ID: 27815417
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Molecular insights into the D1R agonist and D2R/D3R antagonist effects of the natural product (-)-stepholidine: molecular modeling and dynamics simulations.
    Li B; Li W; Du P; Yu KQ; Fu W
    J Phys Chem B; 2012 Jul; 116(28):8121-30. PubMed ID: 22702398
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Morphine-induced antinociception in the formalin test: sensitization and interactions with D1 and D2 dopamine receptors and nitric oxide agents.
    Zarrindast MR; Asgari-Afshar A; Sahebgharani M
    Behav Pharmacol; 2007 May; 18(3):177-84. PubMed ID: 17426481
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diminished natriuretic response to dopamine in old rats is due to an impaired D1-like receptor-signaling pathway.
    Beheray S; Kansra V; Hussain T; Lokhandwala MF
    Kidney Int; 2000 Aug; 58(2):712-20. PubMed ID: 10916094
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dopamine receptor 3: A mystery at the heart of cardiac fibrosis.
    Byrne SE; Vishwakarma N; Sriramula S; Katwa LC
    Life Sci; 2022 Nov; 308():120918. PubMed ID: 36041503
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mesoaccumbens dopamine signaling alteration underlies behavioral transition from tolerance to sensitization to morphine rewarding properties during morphine withdrawal.
    Sun L; Hu L; Li Y; Cui C
    Brain Struct Funct; 2014 Sep; 219(5):1755-71. PubMed ID: 23775491
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Differential effects of oxycodone, hydrocodone, and morphine on the responses of D2/D3 dopamine receptors.
    Emery MA; Bates ML; Wellman PJ; Eitan S
    Behav Brain Res; 2015 May; 284():37-41. PubMed ID: 25617530
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inputs from the basolateral amygdala to the nucleus accumbens shell control opiate reward magnitude via differential dopamine D1 or D2 receptor transmission.
    Lintas A; Chi N; Lauzon NM; Bishop SF; Sun N; Tan H; Laviolette SR
    Eur J Neurosci; 2012 Jan; 35(2):279-90. PubMed ID: 22236063
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nucleus accumbens D2- and D1-receptor expressing medium spiny neurons are selectively activated by morphine withdrawal and acute morphine, respectively.
    Enoksson T; Bertran-Gonzalez J; Christie MJ
    Neuropharmacology; 2012 Jun; 62(8):2463-71. PubMed ID: 22410393
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Deletion of dopamine D1 and D3 receptors differentially affects spontaneous behaviour and cocaine-induced locomotor activity, reward and CREB phosphorylation.
    Karasinska JM; George SR; Cheng R; O'Dowd BF
    Eur J Neurosci; 2005 Oct; 22(7):1741-50. PubMed ID: 16197514
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dopamine D3 receptor ligands modulate the acquisition of morphine-conditioned place preference.
    Francès H; Smirnova M; Leriche L; Sokoloff P
    Psychopharmacology (Berl); 2004 Sep; 175(2):127-33. PubMed ID: 15095031
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lack of age-dependent decrease in dopamine D3 receptor availability: a [(11)C]-(+)-PHNO and [(11)C]-raclopride positron emission tomography study.
    Nakajima S; Caravaggio F; Boileau I; Chung JK; Plitman E; Gerretsen P; Wilson AA; Houle S; Mamo DC; Graff-Guerrero A
    J Cereb Blood Flow Metab; 2015 Nov; 35(11):1812-8. PubMed ID: 26058690
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The effect of morphine on the input neuronal system of the spinal cord, participating in the formation of nociceptive pressor reflexes].
    Beliantseva IA; Lukoshkova EV
    Biull Eksp Biol Med; 1991 Oct; 112(10):365-8. PubMed ID: 1804344
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dopamine D3 receptor knockout mice exhibit abnormal nociception in a sex-different manner.
    Liu P; Xing B; Chu Z; Liu F; Lei G; Zhu L; Gao Y; Chen T; Dang YH
    J Neurosci Res; 2017 Jul; 95(7):1438-1445. PubMed ID: 27716994
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dopamine D1 receptor agonist treatment attenuates extinction of morphine conditioned place preference while increasing dendritic complexity in the nucleus accumbens core.
    Kobrin KL; Arena DT; Heinrichs SC; Nguyen OH; Kaplan GB
    Behav Brain Res; 2017 Mar; 322(Pt A):18-28. PubMed ID: 28089852
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Locomotor and discriminative-stimulus effects of cocaine in dopamine D5 receptor knockout mice.
    Elliot EE; Sibley DR; Katz JL
    Psychopharmacology (Berl); 2003 Sep; 169(2):161-8. PubMed ID: 12768268
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Quantitative changes in Galphaolf protein levels, but not D1 receptor, alter specifically acute responses to psychostimulants.
    Corvol JC; Valjent E; Pascoli V; Robin A; Stipanovich A; Luedtke RR; Belluscio L; Girault JA; Hervé D
    Neuropsychopharmacology; 2007 May; 32(5):1109-21. PubMed ID: 17063155
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.